Risk Factors for Recurrent Retinal Detachment

Risk Factors for Recurrent Retinal Detachment

In this article, the authors seek to identify risk factors associated with surgical failure as defined by recurrent detachment after uncomplicated pars plana vitrectomy (PPV) for primary rhegmatogenous retinal detachment (RRD).

This was a retrospective study of 519 eyes of 509 patients with primary RRD, who underwent PPV with at least 3 months of follow-up. At the surgeon’s discretion, surgical methods could include 23- or 25-gauge, use of an encircling scleral buckle, chandelier illumination, triamcinolone, laser or cryopexy, air or sulfur hexafluoride or silicone oil, and combined phacoemulsification if a cataract was present.

The study excluded more complex retinal detachments including those with grade C1 proliferative vitreoretinopathy (PVR) or worse; presence of giant retinal tears; use of perfluorocarbon liquid; and tractional, exudative or traumatic retinal detachments.

The main outcomes were primary success rate and factors associated with surgical failure. Failure was defined by the need for additional surgery to manage recurrent retinal detachment, or the presence of silicone oil at the last follow-up. Secondary outcomes were visual acuity and postoperative complications.

With regard to baseline characteristics, the mean follow-up duration was 9.8 months, with a range of 3 to 66 months. The majority of eyes (or 424 out of 519) were phakic, and of these, 420 of 424, or 99%, had phacoemulsification in combination with vitrectomy whereas only 4 cases had lens-sparing vitrectomy. An encircling band was used in 6% (or 30 of 519 cases), a drainage retinotomy was made in 41% (or 213 of 519 cases), and the majority 98% (or 509 of 519 cases) got SF6 as a tamponade agent, as opposed to only 1% (or 6 cases) getting air and 1% (or 4 cases) getting silicone oil.

The rate of overall surgical success was 93.8%, although the success rate was 96.4% without drainage retinotomy and 90.1% with drainage retinotomy. Similar rates held up when excluding those 30 cases that received an encircling band as well. Univariate analyses revealed that macula-off status, use of drainage retinotomy, and greater extent of retinal detachment (as defined on a scale of 1-4 quadrants of involvement), were all significantly associated with surgical failure.

Multivariate analysis with logistic regression revealed that, in particular, the use of drainage retinotomy was significantly associated with surgical failure. Propensity score matching was performed to eliminate sample size bias and to control for confounding variables, such as inferior main break, poor preoperative best corrected visual acuity, greater extent of retinal detachment, macula-off status, use of encircling band, and use of silicone oil. After propensity score matching, drainage retinotomy was still associated with surgical failure, as it was noted that eyes with a drainage retinotomy had 3.2 greater odds of surgical failure as compared to eyes without drainage retinotomy (P = .027).

In a sub-analysis of 32 surgical failures (or 6.2% of all 519 cases), 44% were due to reopened original breaks, 22% were due to proliferative vitreoretinopathy, 22% were due to new breaks, and 9% were due to a reopened drainage retinotomy. Of note, epiretinal membrane (ERM) formation occurred in 9% (or 49 or 519 eyes), and of these, one third required additional surgery for membrane peeling. Risk factors for postoperative ERM formation were found to include drainage retinotomy and preoperative PVR on multivariate analysis. Other postoperative complications included macular hole formation in 1% of eyes and macular edema in 6% of eyes. Ocular hypertension in 22% of eyes, and of these 116 cases, 23% (or 27 eyes) required longer term topical glaucoma drops, while 4% (or 5 eyes) required glaucoma surgery.

The authors note that the surgical success rate of 93.8% is higher than average in the published literature. They attribute this to the exclusion of more severe cases, which they also recognize as a limitation of the study. They cite several other limitations including selection bias, variability in surgeon skill, and relatively short mean follow-up.

In the setting of conflicting reports in the literature regarding the association between drainage retinotomy and surgical failure, the authors highlight that drainage retinotomy was the only significant risk factor for surgical failure by multivariate analysis using logistic regression and propensity score matching. They propose that the association between drainage retinotomy and surgical failure might be explained by variable severity of retinal detachments requiring drainage retinotomy, as well as by postsurgical inflammation that may result in ERM and PVR. They conclude by suggesting that the avoidance of drainage retinotomy may improve surgical success rate.

Details
  • Overview

    January 2023: VBS Literature Update

    Ohara H, Yuasa Y, Harada Y, et al. Drainage retinotomy is a risk factor for surgical failure after pars plana vitrectomy in patients with primary uncomplicated rhegmatogenous retinal detachment. Retina. 2022;42(12):2307-2314.

    Abstract by Tamara Lee Lenis, MD, PhD

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Identify potential risk factors for surgical failure in pars plana vitrectomy for primary rhegmatogenous retinal detachment repair
    • Accreditation

       Provided by Evolve Medical Education

      Accreditation Statement
      This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education, LLC and Vit Buckle Society.  Evolve Medical Education, LLC is accredited by the ACCME to provide continuing medical education for physicians.

      Credit Designation Statement
      Evolve Medical Education LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • Participation Method

      In order to obtain credit, proceed through the program, complete the posttest, evaluation and submit for credit.

    • Faculty and Disclosures

      Tamara Lee Lenis, MD, PhD

      Tamara Lee Lenis, MD, PhD

      NJ Retina
      Teaneck, NJ


      DISCLOSURE POLICY
      It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.

      The following faculty/staff members have the following financial relationships with ineligible companies.

      Tamara Lee Lenis, MD, PhD, has no financial relationships with ineligible companies. 

      The Evolve staff and planners have no financial relationships with ineligible companies.
      Nisha Mukherjee, MD, peer reviewer, has no financial relationships with ineligible companies.

    • Disclaimer

      OFF-LABEL STATEMENT
      This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      DISCLAIMER
      The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Vit Buckle Society.

      This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

    • System Requirements

      • Supported Browsers (2 most recent versions):
        • Google Chrome for Windows, Mac OS, iOS, and Android
        • Apple Safari for Mac OS and iOS
        • Mozilla Firefox for Windows, Mac OS, iOS, and Android
        • Microsoft Edge for Windows
      • Recommended Internet Speed: 5Mbps+

    • Publication Dates

      Expiration Date:

    0.25 credits
    Completing the pre-test is required to access this content.
    Completing the pre-survey is required to view this content.

    Ready to Claim Your Credits?

    You have attempts to pass this post-test. Take your time and review carefully before submitting.

    Good luck!

    Register

    We're glad to see you're enjoying Evolve Medical Education…
    but how about a more personalized experience?

    Register for free